{{Rsnum
|rsid=7253363
|Chromosome=19
|position=11571680
|Orientation=plus
|GMAF=0.01837
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=LOC101928434
|Gene_s=LOC101928434
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 86.7 | 13.3 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 95.0 | 5.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 91.4 | 8.6 | 0.0
| MKK | 92.3 | 7.7 | 0.0
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000009
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs7253363
|Name_s=
|Gene_s=ACP5
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 19p13.2; Reported Gene(s): ACP5; Risk Allele: rs7253363-?); (p-value= 0.000009).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740731
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7253363
|overall_frequency_n=126
|overall_frequency_d=128
|overall_frequency=0.984375
|n_genomes=55
|n_genomes_annotated=0
|n_haplomes=109
|n_articles=1
|n_articles_annotated=1
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}